BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis As Assessed by the Static Physician's Global Assessment (spga)/body Surface Area (BSA) Composite Tool (spgaxbsa), a Clinically Useful Alternative to PASI
Skin（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined